Sponsor or institution
Clinical trials and research at JW Pharmaceutical
As of November 12, 2026, Find a Trial lists 6 clinical trials run by JW Pharmaceutical that are recruiting, in South Korea. By phase: Phase 1 (2), Phase 3 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Fixed-dose pitavastatin/ezetimibe for adults with dyslipidemia and metabolic syndrome | — | Daejeon | Recruiting | Apr 13, 2026 |
| Safety and how the body handles JW0061 when applied to the skin of healthy adults | Phase 1 | Seoul, Seoul | Recruiting | Apr 7, 2026 |
| Comparing blood sugar swings with different diabetes pill combinations in type 2 diabetes | Phase 4 | Seoul | Recruiting | Mar 2, 2026 |
| KLH-2109 for heavy menstrual bleeding from uterine fibroids | Phase 3 | Seoul | Recruiting | Jan 30, 2026 |
| Evaluating the safety and effects of JW2286 in healthy volunteers | Phase 1 | Seoul | Recruiting | Nov 25, 2024 |
| Giving JW0104 together with C2402 for people with high blood pressure and high cholesterol | Phase 3 | Seoul | Recruiting | Oct 16, 2024 |
All recruiting trials (6)
-
Fixed-dose pitavastatin/ezetimibe for adults with dyslipidemia and metabolic syndrome
This will try a fixed-dose pitavastatin/ezetimibe pill in adults with dyslipidemia and metabolic syndrome to see if it lowers LDL cholesterol and is safe over 48 weeks.
-
Safety and how the body handles JW0061 when applied to the skin of healthy adults
This trial will test how safe JW0061 is and how it is absorbed and acts when applied to the skin of healthy Korean and Caucasian adults.
-
Comparing blood sugar swings with different diabetes pill combinations in type 2 diabetes
This study will test whether different combinations of empagliflozin, metformin, linagliptin, or anagliptin reduce blood sugar swings in adults with type 2 diabetes who remain uncontrolled on metformin plus an SGLT2 inhibitor.
-
KLH-2109 for heavy menstrual bleeding from uterine fibroids
We are testing whether KLH-2109 can reduce heavy menstrual bleeding in people with uterine fibroids.
-
Evaluating the safety and effects of JW2286 in healthy volunteers
This study is testing a new drug called JW2286 in healthy adults to see if it's safe and how it works in different people after they eat.
-
Giving JW0104 together with C2402 for people with high blood pressure and high cholesterol
This study will test whether taking JW0104 with C2402 helps people who have both hypertension and dyslipidemia control their blood pressure and cholesterol.
Quick answers
How many clinical trials run by JW Pharmaceutical are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.